OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Transcatheter arterial chemoembolization combined with PD-1 inhibitors and Lenvatinib for hepatocellular carcinoma with portal vein tumor thrombus
Hongxiao Wu, Xiaoyan Ding, Yawen Xu, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 8, pp. 843-854
Open Access | Times Cited: 4
Hongxiao Wu, Xiaoyan Ding, Yawen Xu, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 8, pp. 843-854
Open Access | Times Cited: 4
Showing 4 citing articles:
Impact of neoadjuvant multimodal therapy in the setting of locally advanced hepatocellular carcinoma
Daniele Ferraro, Federica Falaschi, Luca Nazzaro, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 28, pp. 3452-3455
Open Access | Times Cited: 1
Daniele Ferraro, Federica Falaschi, Luca Nazzaro, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 28, pp. 3452-3455
Open Access | Times Cited: 1
Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives
Yuhang Chen, Shengyuan Dai, Chienâshan Cheng, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Yuhang Chen, Shengyuan Dai, Chienâshan Cheng, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysis
Yue Chen, Luyao Jia, Yu Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Yue Chen, Luyao Jia, Yu Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Interventional therapy combined with tyrosine kinase inhibitors with or without immune checkpoint inhibitors as initial treatment for hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis
Changjie Du, Hongyu Wu, Tao Zhong, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Changjie Du, Hongyu Wu, Tao Zhong, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
